Home LiteratureArticle Details
PMID: 24722280 Published · epublish English Journal Article Research Support, Non-U.S. Gov't

Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma.

Cell death & disease ·Vol. 5 ·2014-04-10 ·Pages e1155

Wang H, Wu Q, Liu Z, Luo X, Fan Y, Liu Y, Zhang Y, Hua S, Fu Q, Zhao M, Chen Y, Fang W, Lv X

Abstract

It is largely recognized that fibroblast activation protein (FAP) is expressed in cancer-associated fibroblasts (CAFs) of many human carcinomas. Furthermore, FAP was recently also reported to be expressed in carcinoma cells of the breast, stomach, pancreatic ductal adenocarcinoma, colorectum, and uterine cervix. The carcinoma cell expression pattern of FAP has been described in several types of cancers, but the role of FAP in oral squamous cell carcinoma (OSCC) is unknown. The role of endogenous FAP in epithelium-derived tumors and molecular mechanisms has also not been reported. In this study, FAP was found to be expressed in carcinoma cells of OSCC and was upregulated in OSCC tissue samples compared with benign tissue samples using immunohistochemistry. In addition, its expression level was closely correlated with overall survival of patients with OSCC. Silencing FAP inhibited the growth and metastasis of OSCC cells in vitro and in vivo. Mechanistically, knockdown of FAP inactivated PTEN/PI3K/AKT and Ras-ERK and its downstream signaling regulating proliferation, migration, and invasion in OSCC cells, as the inhibitory effects of FAP on the proliferation and metastasis could be rescued by PTEN silencing. Our study suggests that FAP acts as an oncogene and may be a potential therapeutic target for patients with OSCC.

MeSH Terms
Animals Carcinoma, Squamous Cell/enzymology,genetics,pathology Cell Cycle/genetics Cell Movement Cell Proliferation Down-Regulation Endopeptidases Epithelial-Mesenchymal Transition/genetics Female Gelatinases/metabolism Gene Expression Regulation, Neoplastic Gene Knockdown Techniques Gene Silencing Humans MAP Kinase Signaling System Male Matrix Metalloproteinases/metabolism Membrane Proteins/metabolism Mice, Nude Middle Aged Mouth Neoplasms/enzymology,genetics,pathology Neoplasm Invasiveness Neoplasm Metastasis PTEN Phosphohydrolase/metabolism Phosphatidylinositol 3-Kinases/metabolism Prognosis Proto-Oncogene Proteins c-akt/metabolism Serine Endopeptidases/metabolism Xenograft Model Antitumor Assays ras Proteins/metabolism
Chemicals
Membrane Proteins Proto-Oncogene Proteins c-akt PTEN Phosphohydrolase PTEN protein, human Endopeptidases Serine Endopeptidases fibroblast activation protein alpha Gelatinases Matrix Metalloproteinases ras Proteins
Authors & Affiliations
13 authors, click to expand affiliations / ORCID
Wang H
1] Department of Stomatology of Nanfang Hospital, Southern Medical University, Guangzhou, PR China [2] Cancer Research Institute, School of Basic Medicine, Southern Medical University, Guangzhou, PR China.
Wu Q
Cancer Research Institute, School of Basic Medicine, Southern Medical University, Guangzhou, PR China.
Liu Z
1] Cancer Research Institute, School of Basic Medicine, Southern Medical University, Guangzhou, PR China [2] Department of Pathology, School of Basic Medicine, Guangzhou Medical University, Guangzhou, PR China.
Luo X
Cancer Research Institute, School of Basic Medicine, Southern Medical University, Guangzhou, PR China.
Fan Y
Cancer Research Institute, School of Basic Medicine, Southern Medical University, Guangzhou, PR China.
Liu Y
Cancer Research Institute, School of Basic Medicine, Southern Medical University, Guangzhou, PR China.
Zhang Y
Cancer Research Institute, School of Basic Medicine, Southern Medical University, Guangzhou, PR China.
Hua S
Cancer Research Institute, School of Basic Medicine, Southern Medical University, Guangzhou, PR China.
Fu Q
Cancer Research Institute, School of Basic Medicine, Southern Medical University, Guangzhou, PR China.
Zhao M
Cancer Research Institute, School of Basic Medicine, Southern Medical University, Guangzhou, PR China.
Chen Y
Cancer Research Institute, School of Basic Medicine, Southern Medical University, Guangzhou, PR China.
Fang W
1] Department of Stomatology of Nanfang Hospital, Southern Medical University, Guangzhou, PR China [2] Cancer Research Institute, School of Basic Medicine, Southern Medical University, Guangzhou, PR China.
Lv X
1] Department of Stomatology of Nanfang Hospital, Southern Medical University, Guangzhou, PR China [2] Cancer Research Institute, School of Basic Medicine, Southern Medical University, Guangzhou, PR China.
References (39)
39 references, click to expand
  1. The renaissance of GSK3.
    Nat Rev Mol Cell Biol. 2001 Oct;2(10):769-76 PMID: 11584304
  2. MiR-155 inhibits cell migration of human cardiomyocyte progenitor cells (hCMPCs) via targeting of MMP-16.
    J Cell Mol Med. 2012 Oct;16(10):2379-86 PMID: 22348515
  3. Mechanisms of disease: epithelial-mesenchymal transition--does cellular plasticity fuel neoplastic progression?
    Nat Clin Pract Oncol. 2008 May;5(5):280-90 PMID: 18349857
  4. Expression and significance of new tumor suppressor gene PTEN in primary liver cancer.
    J Cell Mol Med. 2003 Jan-Mar;7(1):67-71 PMID: 12767263
  5. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype.
    Cancer Res. 2008 Feb 15;68(4):989-97 PMID: 18281472
  6. KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a.
    Cell Death Dis. 2013 Aug 01;4:e745 PMID: 23907459
  7. Osteopontin promotes gastric cancer metastasis by augmenting cell survival and invasion through Akt-mediated HIF-1alpha up-regulation and MMP9 activation.
    J Cell Mol Med. 2009 Aug;13(8B):1706-1718 PMID: 19602039
  8. Fibroblast activation protein-α promotes ovarian cancer cell proliferation and invasion via extracellular and intracellular signaling mechanisms.
    Exp Mol Pathol. 2013 Aug;95(1):105-10 PMID: 23778090
  9. Cyclin G1-mediated epithelial-mesenchymal transition via phosphoinositide 3-kinase/Akt signaling facilitates liver cancer progression.
    Hepatology. 2012 Jun;55(6):1787-98 PMID: 22271581
  10. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    J Cell Mol Med. 2011 Mar;15(3):691-700 PMID: 20219012
  11. Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers.
    Mod Pathol. 1998 Sep;11(9):855-63 PMID: 9758365
  12. 'Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer'.
    Cancer Lett. 2005 Sep 28;227(2):229-36 PMID: 16196122
  13. Oral tongue squamous cell carcinoma (OTSCC): alcohol and tobacco consumption versus non-consumption. A study in a Portuguese population.
    Braz Dent J. 2011;22(6):517-21 PMID: 22189649
  14. FK506 binding protein 51 positively regulates melanoma stemness and metastatic potential.
    Cell Death Dis. 2013 Apr 04;4:e578 PMID: 23559012
  15. Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial-mesenchymal transition.
    J Cell Mol Med. 2014 Jan;18(1):49-58 PMID: 24305552
  16. Indometacin ameliorates high glucose-induced proliferation and invasion via modulation of e-cadherin in pancreatic cancer cells.
    Curr Med Chem. 2013;20(33):4142-4152 PMID: 23992308
  17. Gα₁₂ drives invasion of oral squamous cell carcinoma through up-regulation of proinflammatory cytokines.
    PLoS One. 2013 Jun 07;8(6):e66133 PMID: 23762476
  18. Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters.
    Cell Death Dis. 2011 Jul 07;2:e179 PMID: 21734725
  19. Pleiotropic actions of miR-21 highlight the critical role of deregulated stromal microRNAs during colorectal cancer progression.
    Cell Death Dis. 2013 Jun 20;4:e684 PMID: 23788041
  20. High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis.
    Tumour Biol. 2013 Apr;34(2):1013-20 PMID: 23328994
  21. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells.
    BMC Cancer. 2011 Jun 13;11:245 PMID: 21668992
  22. Potential tumor suppressor NESG1 as an unfavorable prognosis factor in nasopharyngeal carcinoma.
    PLoS One. 2011;6(11):e27887 PMID: 22140479
  23. ATP citrate lyase knockdown impacts cancer stem cells in vitro.
    Cell Death Dis. 2013 Jun 27;4:e696 PMID: 23807225
  24. Inactivation or loss of TTP promotes invasion in head and neck cancer via transcript stabilization and secretion of MMP9, MMP2, and IL-6.
    Clin Cancer Res. 2013 Mar 1;19(5):1169-79 PMID: 23349315
  25. Expression and role of fibroblast activation protein-alpha in microinvasive breast carcinoma.
    Diagn Pathol. 2011 Nov 08;6:111 PMID: 22067528
  26. The expression of a type II transmembrane serine protease (Seprase) in human gastric carcinoma.
    Oncology. 2004;67(5-6):411-9 PMID: 15713998
  27. Clinical implications of fibroblast activation protein-α in non-small cell lung cancer after curative resection: a new predictor for prognosis.
    J Cancer Res Clin Oncol. 2013 Sep;139(9):1523-8 PMID: 23835897
  28. Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance.
    World J Gastroenterol. 2012 Feb 28;18(8):840-6 PMID: 22371645
  29. PTEN-regulated AKT/FoxO3a/Bim signaling contributes to reactive oxygen species-mediated apoptosis in selenite-treated colorectal cancer cells.
    Cell Death Dis. 2013 Feb 07;4:e481 PMID: 23392169
  30. ERalpha signaling through slug regulates E-cadherin and EMT.
    Oncogene. 2010 Mar 11;29(10):1451-62 PMID: 20101232
  31. The emergence of ECM mechanics and cytoskeletal tension as important regulators of cell function.
    Cell Biochem Biophys. 2007;47(2):300-20 PMID: 17652777
  32. Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma.
    Pancreas. 2008 Aug;37(2):154-8 PMID: 18665076
  33. Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma.
    Cell Death Dis. 2013 May 16;4:e634 PMID: 23681229
  34. Expression of angiopoietin-2 and vascular endothelial growth factor receptor-3 correlates with lymphangiogenesis and angiogenesis and affects survival of oral squamous cell carcinoma.
    PLoS One. 2013 Sep 11;8(9):e75388 PMID: 24040410
  35. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B.
    Nature. 1995 Dec 21-28;378(6559):785-9 PMID: 8524413
  36. Epidermal growth factor receptor mutations in patients with oral cavity cancer in a betel nut chewing-prevalent area.
    Head Neck. 2011 Dec;33(12):1758-64 PMID: 21284055
  37. Expression patterns of seprase, a membrane serine protease, in cervical carcinoma and cervical intraepithelial neoplasm.
    Anticancer Res. 2003 Jul-Aug;23(4):3195-8 PMID: 12926053
  38. Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma.
    Mol Cancer. 2010 Sep 10;9:238 PMID: 20831814
  39. Current aspects on oral squamous cell carcinoma.
    Open Dent J. 2012;6:126-30 PMID: 22930665
Article Info
Journal
Cell death & disease
Abbr.
Cell Death Dis
ISSN
2041-4889
Published
2014-04-10
Epub
2014-00-10
Pages
e1155
Language
English
Region
England
NLM ID
101524092
PMCID
PMC5424105
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]